Financial News

Biotech Skin Health Brand OneSkin Closes Series A Investment Round

Unilever Ventures is among investors in this San Francisco-based maker of topical skin longevity treatments.

OneSkin founders

San Francisco-based skin care brand OneSkin has closed its Series A investment round, bringing total funding for the brand to $20 million.

Founded by four Brazilian PhD scientists in 2016, OneSkin offers topical skin longevity treatments. The company says its patented peptide and core ingredient, OS-01, reverses skin’s biological age by preventing the accumulation of senescent cells, a major driver of aging.

The oversubscribed round was led by Selva Ventures, alongside with PLUS Capital, Unilever Ventures, Able Partners, and former investors SOSV and Meta Planet. Additional investors include Brazilian-American model and designer Camila Alves McConaughey and tech entrepreneur Kevin Rose. 

“At OneSkin, we are excited to announce this new round of funding, which will further drive our mission to transform how we think about our skin, not only by optimizing our aesthetics using cutting-edge science, but also focusing on its functional role as our largest organ and the impact in our overall health and longevity,” said Carolina Oliveira, co-founder and CEO.

“This investment will allow us to deepen our commitment to be the best in class in delivering efficacious peptides to modulate aging at the cellular level, ensuring that our science-backed solutions deliver measurable results in promoting healthier skin. We are dedicated to advancing the future of skin health with the most advanced longevity research and innovation,” shared Dr. Alessandra Zonari, Co-Founder and CSO of OneSkin.

Funding will fuel accelerated research and novel formulas, delivering expanded longevity solutions and rewriting a new way forward for the anti-aging skincare industry, according to OneSkin. The company plans to increase human capital focused on growth opportunities and new sales channels.

“After working with the OneSkin team over the past two years, we are thrilled to deepen our partnership by leading their Series A round. This is our firm’s largest investment, reflecting our high conviction in the company and the team, led by Carolina and Alessandra,” said Madeline Kaplan, partner at Selva Ventures. “We are seeing the beauty and wellness spaces converge as more consumers want efficacious products that make them look and feel their best. OneSkin is well-positioned at the intersection of beauty and wellness, delivering exceptional results that improve both skin appearance and skin health.”

OneSkin was recently named one of Fast Company’s Most Innovative Companies of 2024.

Keep Up With Our Content. Subscribe To Happi Newsletters